Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Carl Zeiss Meditec AGXSWX:AFX 75 Days Sales Outstanding is 40.90 as of Dec. 2025, which is 8% below its 10-year median of 44.35. GuruFocus rates XSWX:AFX with a GF Score™ of 75/100 and a GF Value™ of CHF69.15. The stock has 4 warning signs investors should review. Among 810 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 90.12% on this metric.
The historical rank and industry rank for Carl Zeiss Meditec AG's Days Sales Outstanding or its related term are showing as below:
XSWX:AFX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.21 Med: 44.35 Max: 62.72
Current: 33.21
During the past 13 years, Carl Zeiss Meditec AG's highest Days Sales Outstanding was 62.72. The lowest was 33.21. And the median was 44.35.
XSWX:AFX's Days Sales Outstanding is ranked better than 90.12% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 66.35
vs XSWX:AFX: 33.21
Carl Zeiss Meditec AG's Days Sales Outstanding
increased
from Dec. 2024 (39.17) to Dec. 2025 (40.90).
Carl Zeiss Meditec AG (XSWX:AFX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Carl Zeiss Meditec AG Days Sales Outstanding Related Terms
Carl Zeiss Meditec AG Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG Days Sales Outstanding Chart
XSWX:AFX vs ISRG, BDX, MDLN: Days Sales Outstanding Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Days Sales Outstanding falls into.
Carl Zeiss Meditec AG Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (XSWX:AFX) has a Days Sales Outstanding of 40.90 as of Dec. 2025. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Carl Zeiss Meditec AG and its competitors. This is near median its historical median of 44.35. Over the past decade, Carl Zeiss Meditec AG's Days Sales Outstanding has ranged from 33.21 to 62.72. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #80 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 9.9%.
Is Carl Zeiss Meditec AG's Days Sales Outstanding too high?
Carl Zeiss Meditec AG's current Days Sales Outstanding of 40.90 is near median its 10-year median of 44.35. Over the past 10 years, this metric has ranged from a low of 33.21 to a high of 62.72. The Medical Devices & Instruments industry median Days Sales Outstanding is 66.35. Carl Zeiss Meditec AG's value of 40.90 is 38.4% below this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #80 out of 810 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Carl Zeiss Meditec AG has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Days Sales Outstanding compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #80 out of 810 companies for Days Sales Outstanding. This places Carl Zeiss Meditec AG in the top 10% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 66.35. Carl Zeiss Meditec AG's value of 40.90 is 38.4% below this benchmark. Historically, Carl Zeiss Meditec AG's own Days Sales Outstanding has ranged from 33.21 to 62.72 over the past decade. While the company's 10-year median is 44.35 vs. the industry median of 66.35, Carl Zeiss Meditec AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 66.35, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current Days Sales Outstanding of 40.90 is 38.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 66.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current Days Sales Outstanding is 40.90, which is near median its own 10-year median of 44.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Carl Zeiss Meditec AG (XSWX:AFX) has a current Days Sales Outstanding of 40.90. The stock's GF Value™ is CHF69.15, compared to a current price of CHF28.14 — trading 59.3% below its estimated fair value. The current Days Sales Outstanding is 40.90, which is near median its 10-year median of 44.35 and 38.4% below the Medical Devices & Instruments industry median of 66.35. Carl Zeiss Meditec AG's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Days Sales Outstanding is 40.90 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of CHF28.14 is trading 59.3% below its estimated GF Value™ of CHF69.15.
Key valuation signals for XSWX:AFX:
Days Sales Outstanding: 40.90 (near median its 10-year median of 44.35)
GF Value™: CHF69.15 vs. price of CHF28.14 (59.3% below fair value)
Industry Position: 38.4% below the Medical Devices & Instruments median (#80 of 810)
No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
75GF Score
Get the complete analysis for XSWX:AFX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AFX has been successfully added to your 
